Henderson, JT; Whitlock, EP; O'Connor, E; Senger, CA; Thompson, JH; Rowland, MG (20 de maio de 2014). "Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.". Annals of Internal Medicine160 (10). pp. 695–703. PMID24711050. doi:10.7326/M13-2844.
Smith, JM; Lowe, RF; Fullerton, J; Currie, SM; Harris, L; Felker-Kantor, E (5 de febreiro de 2013). "An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.". BMC pregnancy and childbirth13. p. 34. PMC3570392. PMID23383864. doi:10.1186/1471-2393-13-34.
McDonald, SD; Lutsiv, O; Dzaja, N; Duley, L (agosto de 2012). "A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.". International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics118 (2). pp. 90–6. PMID22703834. doi:10.1016/j.ijgo.2012.01.028.
Abalos, E; Cuesta, C; Grosso, AL; Chou, D; Say, L (setembro de 2013). "Global and regional estimates of preeclampsia and eclampsia: a systematic review.". European journal of obstetrics, gynecology, and reproductive biology170 (1). pp. 1–7. PMID23746796. doi:10.1016/j.ejogrb.2013.05.005.
Arulkumaran, N.; Lightstone, L. (decembro de 2013). "Severe pre-eclampsia and hypertensive crises". Best Practice & Research Clinical Obstetrics & Gynaecology27 (6). pp. 877–884. PMID23962474. doi:10.1016/j.bpobgyn.2013.07.003.
Henderson, JT; Whitlock, EP; O'Connor, E; Senger, CA; Thompson, JH; Rowland, MG (20 de maio de 2014). "Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.". Annals of Internal Medicine160 (10). pp. 695–703. PMID24711050. doi:10.7326/M13-2844.
Smith, JM; Lowe, RF; Fullerton, J; Currie, SM; Harris, L; Felker-Kantor, E (5 de febreiro de 2013). "An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.". BMC pregnancy and childbirth13. p. 34. PMC3570392. PMID23383864. doi:10.1186/1471-2393-13-34.
McDonald, SD; Lutsiv, O; Dzaja, N; Duley, L (agosto de 2012). "A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.". International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics118 (2). pp. 90–6. PMID22703834. doi:10.1016/j.ijgo.2012.01.028.
Abalos, E; Cuesta, C; Grosso, AL; Chou, D; Say, L (setembro de 2013). "Global and regional estimates of preeclampsia and eclampsia: a systematic review.". European journal of obstetrics, gynecology, and reproductive biology170 (1). pp. 1–7. PMID23746796. doi:10.1016/j.ejogrb.2013.05.005.
Arulkumaran, N.; Lightstone, L. (decembro de 2013). "Severe pre-eclampsia and hypertensive crises". Best Practice & Research Clinical Obstetrics & Gynaecology27 (6). pp. 877–884. PMID23962474. doi:10.1016/j.bpobgyn.2013.07.003.